Dilafor Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
2ndary - Private
- Investors
-
7
Dilafor General Information
Description
Porvider of pharmaceutical products intended to contribute towards the healthy lives of mothers, children, and families. The company's products are proprietary heparan sulfate mimetics for the optimal effectiveness of oxytocin and prostaglandins, which treat severe fetal asphyxia and postpartum hemorrhage, enabling physicians to reduce these risks associated with protracted labor.
Contact Information
Website
www.dilafor.comCorporate Office
- Karolinska Institutet Science Park
- Fogdevreten 2A
- 171 65 Solna
- Sweden
Corporate Office
- Karolinska Institutet Science Park
- Fogdevreten 2A
- 171 65 Solna
- Sweden
Dilafor Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 10. Later Stage VC | 31-Dec-2021 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 23-Apr-2019 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 31-Dec-2018 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 31-Dec-2017 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 27-Sep-2016 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 31-Dec-2014 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 31-Dec-2013 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 13-Feb-2013 | $3.01M | Completed | Generating Revenue | ||
| 2. Later Stage VC | 31-Dec-2011 | $3.01M | $3.01M | Completed | Generating Revenue |
Dilafor Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | ||||||||
| Preference | ||||||||
| Preference | ||||||||
| Preference | ||||||||
| Preference | ||||||||
| Preference | ||||||||
| Preference | ||||||||
| Preference | 20,974 | $54.87 | $54.87 | 1x | $54.87 | 1.58% | ||
| Preference | 36,599 | $61.77 | $61.77 | 1x | $61.77 | 2.75% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Dilafor Patents
Dilafor Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12419904-B2 | Medical use of tafoxiparin | Active | 03-May-2022 | ||
| US-12611423-B2 | Medical use of tafoxiparin | Active | 03-May-2022 | ||
| US-20230355658-A1 | Medical use of tafoxiparin | Active | 03-May-2022 | ||
| US-20250177435-A1 | Medical use of tafoxiparin | Active | 03-May-2022 | ||
| AU-2023266079-A1 | New medical use of tafoxiparin | Pending | 03-May-2022 | A61K31/727 |
Dilafor Signals
Dilafor Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Opocrin | Corporation | Minority | ||
| Lee's Pharmaceutical Holdings | Corporation | Minority | ||
| Östersjöstiftelsen | Limited Partner | Minority | ||
| Pila Pharma | Corporation | Minority | ||
| b2venture | Venture Capital | Minority |
Dilafor FAQs
-
When was Dilafor founded?
Dilafor was founded in 2003.
-
Where is Dilafor headquartered?
Dilafor is headquartered in Solna, Sweden.
-
What is the size of Dilafor?
Dilafor has 4 total employees.
-
What industry is Dilafor in?
Dilafor’s primary industry is Drug Discovery.
-
Is Dilafor a private or public company?
Dilafor is a Private company.
-
What is Dilafor’s current revenue?
The current revenue for Dilafor is .
-
How much funding has Dilafor raised over time?
Dilafor has raised $26.5M.
-
Who are Dilafor’s investors?
Opocrin, Lee's Pharmaceutical Holdings, Östersjöstiftelsen, Pila Pharma, and b2venture are 5 of 7 investors who have invested in Dilafor.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process